INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q1 2020
Shares 40,000 Value ($000) $2,518 Avg Close — Range —
Q4 2019
Shares 40,000 Value ($000) $4,957 Avg Close — Range —
Q3 2019
Shares 47,600 Value ($000) $3,159 Avg Close — Range —
Q2 2019
Shares 37,600 Value ($000) $2,992 Avg Close — Range —
Q4 2017
Shares 38,500 Value ($000) $2,249 Avg Close — Range —
Q3 2017
Shares 40,000 Value ($000) $2,322 Avg Close — Range —
Q2 2017
Shares 3,008 Value ($000) $364 Avg Close — Range —
Q1 2017
Shares 30,000 Value ($000) $3,393 Avg Close — Range —
Q4 2016
Shares 20,000 Value ($000) $2,173 Avg Close — Range —
Q3 2016
Shares 10,000 Value ($000) $1,645,900 Avg Close — Range —
Q4 2015
Shares 26,000 Value ($000) $3,883 Avg Close — Range —
Q3 2015
Shares 32,000 Value ($000) $5,308 Avg Close — Range —
Q2 2015
Shares 24,000 Value ($000) $5,793 Avg Close — Range —
Q1 2015
Shares 23,000 Value ($000) $6,486 Avg Close — Range —
Q4 2014
Shares 22,000 Value ($000) $3,432 Avg Close — Range —
Q3 2014
Shares 18,600 Value ($000) $4,402 Avg Close — Range —